×
Entrez Id:
23583
Gene Symbol:
SMUG1
SMUG1
melanoma
0.100
Biomarker
BEFREE
We included patients with malignant melanoma who underwent a single injection [<sup>18</sup>F]FDG dual-imaging protocol that included whole-body PET/CT and subsequent whole-body PET/MRI for staging or restaging purposes in a prospective setting.
31363965
2019
×
Entrez Id:
23583
Gene Symbol:
SMUG1
SMUG1
melanoma
0.100
Biomarker
BEFREE
Detecting BRAFV600 status in melanoma based on <sup>18</sup>F-FDG PET/CT alone does not yet provide clinically relevant knowledge.
31481581
2019
×
Entrez Id:
23583
Gene Symbol:
SMUG1
SMUG1
melanoma
0.100
Biomarker
BEFREE
18F-FDG PET/CT of Multiorgan Sarcoid-Like Reaction During Anti-PD-1 Treatment for Melanoma .
31584495
2019
×
Entrez Id:
23583
Gene Symbol:
SMUG1
SMUG1
melanoma
0.100
GeneticVariation
BEFREE
Positron emission tomography (PET)-CT in May 2017 identified an FDG avid omental deposit; consistent histologically with MM when resected.
30665926
2019
×
Entrez Id:
23583
Gene Symbol:
SMUG1
SMUG1
melanoma
0.100
Biomarker
BEFREE
Prediction of response to immune checkpoint inhibitor therapy using 18F-FDG PET/CT in patients with melanoma .
31335691
2019
×
Entrez Id:
23583
Gene Symbol:
SMUG1
SMUG1
melanoma
0.100
Biomarker
BEFREE
The current meta-analysis showed a high sensitivity and specificity of 18F-FDG -PET or PET/CT for the detection of recurrent disease after treatment of MM .
31437839
2019
×
Entrez Id:
23583
Gene Symbol:
SMUG1
SMUG1
melanoma
0.100
Biomarker
BEFREE
Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma ?
29876618
2018
×
Entrez Id:
23583
Gene Symbol:
SMUG1
SMUG1
melanoma
0.100
Biomarker
BEFREE
Feasibility of clinical imaging of increased splenic FDG uptake was demonstrated in a melanoma patient participating in a clinical phase 1 trial of a tetravalent RNA-lipoplex cancer vaccine.
30112704
2018
×
Entrez Id:
23583
Gene Symbol:
SMUG1
SMUG1
melanoma
0.100
Biomarker
BEFREE
<sup>18</sup>F-FDG PET imaging has transformed diagnostic nuclear medicine and has become an essential component in the management of melanoma , but still has its drawbacks.
29085965
2018
×
Entrez Id:
23583
Gene Symbol:
SMUG1
SMUG1
melanoma
0.100
GeneticVariation
BEFREE
Hibernoma as an incidental finding in the 18F-FDG PET/CT of a patient with melanoma .
30358644
2018
×
Entrez Id:
23583
Gene Symbol:
SMUG1
SMUG1
melanoma
0.100
Biomarker
BEFREE
Subsequent F-FDG PET/CT and excision confirmed this to be an in-transit melanoma metastasis.
29742609
2018
×
Entrez Id:
23583
Gene Symbol:
SMUG1
SMUG1
melanoma
0.100
Biomarker
BEFREE
The aim of the study was to evaluate if 18F-FDG -PET has the potential to detect complete responders to PD1-therapy in patients with unresectable metastasized melanoma two weeks after therapy initiation.
28831583
2018
×
Entrez Id:
23583
Gene Symbol:
SMUG1
SMUG1
melanoma
0.100
Biomarker
BEFREE
FDG PET/CT has high sensitivity and specificity for the detection of distant metastases from cutaneous melanoma .
27775937
2017
×
Entrez Id:
23583
Gene Symbol:
SMUG1
SMUG1
melanoma
0.100
AlteredExpression
BEFREE
We present a case of melanoma in sinuses without abnormal F-FDG activity anywhere in the scanned portion of the body.
28872554
2017
×
Entrez Id:
23583
Gene Symbol:
SMUG1
SMUG1
melanoma
0.100
Biomarker
BEFREE
Unusual diffuse liver <sup>18</sup>F-FDG uptake in melanoma patient treated by ipilimumab.
28697198
2017
×
Entrez Id:
23583
Gene Symbol:
SMUG1
SMUG1
melanoma
0.100
Biomarker
BEFREE
The Advantages and Challenges of Using FDG PET/CT for Response Assessment in Melanoma in the Era of Targeted Agents and Immunotherapy.
28389693
2017
×
Entrez Id:
23583
Gene Symbol:
SMUG1
SMUG1
melanoma
0.100
Biomarker
BEFREE
Ipilimumab-Induced Organizing Pneumonia on 18F-FDG PET/CT in a Patient With Malignant Melanoma .
28481788
2017
×
Entrez Id:
23583
Gene Symbol:
SMUG1
SMUG1
melanoma
0.100
Biomarker
BEFREE
FDG PET/CT is a suitable modality for early detection of asymptomatic recurrence of malignant melanoma .
28154879
2017